Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells

Simvastatin (SMV) is an antihyperlipidemic agent that has been investigated as a possible anti-cancer agent. An obstacle to malignant tumor therapy using drugs is the delivery of adequate levels to the cancer cells while minimizing side effects following their systemic administration. To circumvent...

Descripción completa

Detalles Bibliográficos
Autores principales: Badr-Eldin, Shaimaa M., Aldawsari, Hibah M., Alhakamy, Nabil A., Fahmy, Usama A., Ahmed, Osama A. A., Neamatallah, Thikryat, Tima, Singkome, Almaghrabi, Raghad H., Alkudsi, Fayda M., Alamoudi, Asmaa A., Alzahrani, Amjad A., Kotta, Sabna, Al-hejaili, Omar D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143367/
https://www.ncbi.nlm.nih.gov/pubmed/35631609
http://dx.doi.org/10.3390/pharmaceutics14051024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143367/
https://www.ncbi.nlm.nih.gov/pubmed/35631609
http://dx.doi.org/10.3390/pharmaceutics14051024

Ejemplares similares